Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by Oilersgoforcupon Nov 13, 2020 11:05am
817 Views
Post# 31894966

Party is about to start !!

Party is about to start !!**The Company believes that COVID-19 is expected to remain an active virus affecting human populations for the next 15-21 months

New Partners • Mercer’s VIP Program • Companies/Employers eg: travel groups/airlines • Large Physician Groups eg: urgent care centers • States, Counties, Cities

Aristotle® • Publish data, clinically validate, prepare for first commercial launch

** Grown network to 8,000+ draw sites and 10,000 mobile phlebotomists in US through the Company’s partner physicians

• Outside of COVID-19, the global telehealth market was valued at US$50B in 2018 and is predicted to reach US$267B by 2026

Capacity of 1,000 COVID-19 tests per day, ramping up to 3,000 tests per day via use of proceeds.....you don't ramp up unless you are already doing 1,000 tests per day!!

• COVID Interest in excess of 250,000 tests, including from the City of Alpharetta (Georgia)

Time is now to invest, we are days away from closing the PP and Q3.  

Good Luck to all !!

I am ALL IN !!

All info you need in link below.

https://sedar.com/GetFile.do?lang=EN&docClass=33&issuerNo=00009903&issuerType=03&projectNo=03124157&docId=4817555

Bullboard Posts